- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 06, 2024, 08:40:53 AM
- Local Time:
- May 27, 2024, 08:41:55 PM
- Last Active:
- May 06, 2024, 03:08:01 PM
Signature:
Tyrosine kinase inhibitors (TKIs) continue being the particular mainstay of treatment for people that have persistent myeloid leukemia (CML); nonethel